Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Pogatzki el at
Metabolic improvements extend beyond weight loss
No IGF-1 or glucose disruption: Unlike HGH, AOD-9604 does not significantly increase IGF-1 or negatively affect insulin sensitivity, making it a safer candidate for metabolic regulation Benefits of AOD-9604 When dosed consistently, AOD-9604 provides targeted fat-burning and metabolic support without the systemic hormonal risks seen with full-length HGH
Whether you prefer a fast in-clinic visit in Beverly Hills or Arcadia or the convenience of mobile service brought directly to your home, office or hotel, our licensed clinical team delivers a streamlined experience focused on comfort and professionalism
Methods Trial Design REDEFINE 1 (NCT05567796) was a phase 3, double-blind, placebo-controlled, and active-controlled multicenter trial conducted in 22 countries from November 1, 2022, to June 28, 2023
US$ 21.35
US$ 20.11
US$ 26.90
